Induced Degradation of Lineage-specific Oncoproteins Drives the Selective PARP1 Inhibitor Toxicity in Small Cell Lung Cancer
This study identifies PARPi-induced degradation of lineage-specific oncoproteins as a mechanism for PARP1 inhibitor toxicity in SCLC, showing improved cytotoxicity when combined with targeted agents.
bioRxiv · Nov 2, 2022 · PreprintCancer Biology